Latest & greatest articles for asthma

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on asthma or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on asthma and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for asthma

1161. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma

Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma Kelloway JS Authors' objectives To review the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of zafirlukast for the treatment of asthma. Searching MEDLINE was searched, but no details of the search (...) strategy were provided. Study selection Study designs of evaluations included in the review Double-blind, placebo-controlled trials were included. Specific interventions included in the review Zafirlukast (both oral and aerosol). Participants included in the review Patients with asthma were included. Outcomes assessed in the review Asthma symptoms, concomitant beta-agonist use, pulmonary function, and the safety profile were assessed. How were decisions on the relevance of primary studies made

DARE.1997

1162. Metered-dose inhaler accessory devices in acute asthma. Efficacy and comparison with nebulizers: a literature review

Metered-dose inhaler accessory devices in acute asthma. Efficacy and comparison with nebulizers: a literature review Metered-dose inhaler accessory devices in acute asthma. Efficacy and comparison with nebulizers: a literature review Metered-dose inhaler accessory devices in acute asthma. Efficacy and comparison with nebulizers: a literature review Amirav I, Newhouse M T Authors' objectives To evaluate the efficacy of metered-dose inhalers (MDIs) and accessory devices (ADs) in the management (...) of acute asthma in children, and to compare the outcome with small volume nebulisers (SVNs), which represent the current standard of care. Searching MEDLINE was searched from 1980 to 1996 for publications in the English language, using the keywords 'acute asthma', 'children', 'aerosols' and 'nebulizers'. The reference lists of the retrieved studies were examined, and citation searches were made using the Science Citation Index. The authors of the primary studies were also contacted for additional

DARE.1997

1163. Cost effectiveness of an allergy consultation in the management of asthma

Cost effectiveness of an allergy consultation in the management of asthma Cost effectiveness of an allergy consultation in the management of asthma Cost effectiveness of an allergy consultation in the management of asthma Westley C R, Spiecher B, Starr L, Simons P, Sanders B, Marsh W, Comer C, Harvey R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Use of an allergist consultation (asthma/allergy specialist evaluation) for moderately severe and severe asthma patients in the framework of a large staff-model health maintenance organization (HMO). Some of the components reported to be incorporated in the asthma/allergy consultation were as follows: attempts to identify triggers, individualising home care plans with use

NHS Economic Evaluation Database.1997

1164. Cost-effective management of malignant potentially fatal asthma

Cost-effective management of malignant potentially fatal asthma Cost-effective management of malignant potentially fatal asthma Cost-effective management of malignant potentially fatal asthma Levenson T, Grammar L C, Yarnold P R, Patterson R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Asthma management intervention programme tailored for specific patients with malignant potentially fatal asthma. The programme included regular clinic visits, patient and family education, 24-hour telephone access, simplified medical regimens, adequate anti-inflammatory medication and, if indicated, psychiatric referral. These measures included the building of doctor/patient relations and, for some, the use of depot injections

NHS Economic Evaluation Database.1997

1165. Care of asthma: allergy clinic versus emergency room

Care of asthma: allergy clinic versus emergency room Care of asthma: allergy clinic versus emergency room Care of asthma: allergy clinic versus emergency room Moore C M, Ahmed I, Mouallem R, May W, Ehlayel M, Sorensen R U Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Allergy clinics and emergency room treatment for asthma. Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis. Study population Asthmatic patients (children) from an inner-city area in the USA. All patients came from low income, working families without medical insurance and were ineligible for Medicaid. Setting Hospital. The study was carried out at the Medical Center of Louisiana in New Orleans, USA. Dates to which data relate

NHS Economic Evaluation Database.1997

1166. Cost effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma

Cost effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma Cost effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma Cost effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma Liljas B, Stahl E, Pauwels R A Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two different kinds of inhalers: using an aerosol pressurised metered dose inhaler (pMDI) or a dry powder inhaler (Turbuhaler) in patients with asthma. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population

NHS Economic Evaluation Database.1997

1167. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma.

Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. 10213547 1999 04 27 1999 04 27 2015 06 16 0140-6736 350 9084 1997 Oct 11 Lancet (London, England) Lancet Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. 1060-4 Inhalation therapy with sodium cromoglycate is recommended as the first-line prophylactic treatment for moderate asthma in children. The availability of spacer (...) devices with face-masks has extended the applicability of metered-dose inhalers to younger children. We studied the feasibility and effects of this therapy compared with placebo in children aged 1-4 years. 218 children aged 1-4 years with moderate asthma were recruited through 151 general practitioners between March, 1995, and March, 1996. They were randomly assigned sodium cromoglycate (10 mg three times daily) or placebo, given by inhaler with spacer device and face-mask for 5 months. Rescue

Lancet1997

1168. A controlled trial of immunotherapy for asthma in allergic children.

A controlled trial of immunotherapy for asthma in allergic children. 9011784 1997 02 06 1997 02 06 2007 11 14 0028-4793 336 5 1997 Jan 30 The New England journal of medicine N. Engl. J. Med. A controlled trial of immunotherapy for asthma in allergic children. 324-31 Injections of allergens are widely prescribed for patients with asthma, but little is known about the effectiveness of immunotherapy. We conducted a double-blind, placebo-controlled trial of multiple-allergen immunotherapy in 121 (...) allergic children with moderate-to-severe, perennial asthma. The children, who required daily medication for their asthma, were randomly assigned to receive subcutaneous injections of either a mixture of up to seven aeroallergen extracts or a placebo. Maintenance injections were continued for 18 months or longer. Medications were adjusted every two to three weeks on the basis of peak flow rates and symptoms. The principal outcome was the daily medication score. Bronchial sensitivity to methacholine

NEJM1997

1169. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children.

Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. 9024371 1997 02 28 1997 02 28 2015 06 16 0140-6736 349 9048 1997 Feb 01 Lancet (London, England) Lancet Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. 301-5 The mainstay of treatment for acute asthma in children is nebulised beta 2-adrenergic agents such as salbutamol, given with corticosteroids. However, penetration of the drug to the small (...) airways is impeded by obstruction so intravenous salbutamol may be more effective. We assessed the use of intravenous salbutamol in the management of children with acute severe asthma in a double-blind randomised study. Children who presented to the Emergency Department of Westmead Hospital, Sydney, Australia with asthma were assessed with a clinical assessment scale, and those with severe acute asthma were given nebulised salbutamol at a dose of 2.5 mg (age < or = 2 years) or 5.0 mg (age > 2 years

Lancet1997

1170. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. 9358137 1997 11 13 1997 11 13 2015 11 19 0028-4793 337 20 1997 Nov 13 The New England journal of medicine N. Engl. J. Med. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. 1405-11 The role of long-acting, inhaled beta2-agonists (...) in treating asthma is uncertain. In a double-blind study, we evaluated the effects of adding inhaled formoterol to both lower and higher doses of the inhaled glucocorticoid budesonide. After a four-week run-in period of treatment with budesonide (800 microg twice daily), 852 patients being treated with glucocorticoids were randomly assigned to one of four treatments given twice daily by means of a dry-powder inhaler (Turbuhaler): 100 microg of budesonide plus placebo, 100 microg of budesonide plus 12

NEJM1997

1171. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. 9358138 1997 11 13 1997 11 13 2013 11 21 0028-4793 337 20 1997 Nov 13 The New England journal of medicine N. Engl. J. Med. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. 1412-8 Inhaled glucosteroids and oral theophylline are widely used to treat asthma. We compared the benefits of adding theophylline to inhaled (...) and similar reductions in beta2-agonist use and the variability of peak expiratory flow, a correlate of bronchial hyperresponsiveness and the severity of asthma. Serum cortisol concentrations were significantly reduced in the group given high-dose budesonide (from a mean [+/-SE] of 18.4+/-2.4 microg per deciliter to 15.9+/-2.1 microg per deciliter, P=0.02) but were unchanged in the other group. The median serum theophylline concentration was 8.7 microg per milliliter (therapeutic range, 10 to 20) among

NEJM1997

1172. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. 9385125 1997 12 04 1997 12 04 2015 11 19 0028-4793 337 23 1997 Dec 04 The New England journal of medicine N. Engl. J. Med. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. 1659-65 An inhaled glucocorticoid is currently the medication of choice (...) for long-term control of persistent asthma in children. The role of long-acting beta2-adrenergic-receptor agonists, such as salmeterol, needs to be defined. We conducted a randomized, double-blind, placebo-controlled, parallel-group, one-year study of 241 children (mean [+/-SD] age, 9.3+/-2.4 years) with clinically stable asthma and less than one month of prior glucocorticoid use. We compared inhaled beclomethasone dipropionate (200 microg twice daily) with salmeterol xinafoate (50 microg twice daily

NEJM1997

1173. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study. 9167559 1997 06 11 1997 06 11 2015 11 19 0959-8138 314 7092 1997 May 17 BMJ (Clinical research ed.) BMJ Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study. 1441-6 To determine the effect of adding salmeterol 50 micrograms twice daily for six months to current treatment in subjects with asthma who control their inhaled (...) corticosteroid dose according to a management plan. A double blind, randomised crossover study. Nottingham. 101 subjects with mild or moderate asthma taking at least 200 micrograms twice daily of beclomethasone dipropionate or budesonide. Salmeterol 50 micrograms twice daily and placebo for six months each, with a one month washout. Subjects adjusted inhaled steroid dose according to guidelines. Reduction in inhaled steroid use, exacerbations of asthma, and use of oral steroids. Data were available for 87

BMJ1997 Full Text: Link to full Text with Trip Pro

1174. Zafirlukast (Accolate) in asthma

Zafirlukast (Accolate) in asthma Zafirlukast (Accolate) in asthma Zafirlukast (Accolate) in asthma Booth-Clibborn N, Best L, Stevens A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Booth-Clibborn N, Best L, Stevens A. Zafirlukast (Accolate) in asthma. Southampton: Wessex Institute for Health Research and Development (WIHRD) 1996 Authors (...) ' objectives The author evaluates whether zafirlukast should be offered to patients with mild to moderate asthma, who are currently treated at Step 2 of the British Thoracic Society guidelines, ie. prescribed bronchodilators and corticosteroids. Authors' conclusions The authors conclude that corticosteroids are likely to remain the major treatment for mild to moderate asthma patients for the near future. There is insufficient evidence of zafirlukast's effectiveness in long-term management and for routine

Health Technology Assessment (HTA) Database.1996

1175. Organisation of asthma care: what difference does it make. A systematic review of the literature

Organisation of asthma care: what difference does it make. A systematic review of the literature Organisation of asthma care: what difference does it make. A systematic review of the literature Organisation of asthma care: what difference does it make. A systematic review of the literature Eastwood A J, Sheldon T A Authors' objectives To evaluate the effectiveness of different forms of delivery of asthma care. Searching MEDLINE was searched from 1976 to the first quarter of 1995 using (...) the search terms provided in the Appendix. CINAHL, HELMIS, Manchester Primary and Secondary Care Interface, Health Planning and Administration, and DHSS databases were also searched. Additional material was located by examining relevant citations from identified articles, and by contacting members of the National Asthma Guidelines working party. Study selection Study designs of evaluations included in the review The review included all type of studies assessing organisational methods of asthma management

DARE.1996

1176. Meta-analysis of the effects of psychoeducational care in adults with asthma

Meta-analysis of the effects of psychoeducational care in adults with asthma Meta-analysis of the effects of psychoeducational care in adults with asthma Meta-analysis of the effects of psychoeducational care in adults with asthma Devine E C Authors' objectives To carry out a meta-analysis of relevant intervention studies examining the treatment effects of psychoeducational care in adults with asthma. Searching CINAHL, MEDLINE, Dissertation Abstracts International and PsycLIT searched using (...) the following keywords: 'asthma', 'patient/client education', 'counselling', 'behavioural therapy', 'pulmonary rehabilitation' and 'relaxation therapy'. Additional material was identified by examining conference proceedings from relevant conferences, dissertations obtained graduate programmes in nursing and from University Microfilms International, and the reference lists of relevant studies and reviews. Study selection Study designs of evaluations included in the review Experimental, quasi-experimental

DARE.1996

1177. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden

Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden Gerdtham U G, Hertzman P, Jonsson B, Boman G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) critical assessment on the reliability of the study and the conclusions drawn. Health technology Inhaled corticosteroids in the treatment of asthmatic patients. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Swedish inhabitants. Setting Clinic. The economic study was carried out in Sweden. Dates to which data relate The effectiveness and resource utilisation data were collected between 1978 and 1991 (except for 1984 in-patient care data which were

NHS Economic Evaluation Database.1996

1178. A comparison of the cost effectiveness of alternative prophylactic therapies in childhood asthma

A comparison of the cost effectiveness of alternative prophylactic therapies in childhood asthma A comparison of the cost effectiveness of alternative prophylactic therapies in childhood asthma A comparison of the cost effectiveness of alternative prophylactic therapies in childhood asthma Booth P C, Wells N E, Morrison A K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Prophylactic treatment of asthma in childhood by fluticasone versus sodium cromoglycate. Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis. Study population Patients were aged between 4 and 12 years, had a clinical history of asthma, and were already receiving bronchodilator therapy. 305 children were recruited

NHS Economic Evaluation Database.1996

1179. Theophylline in acute childhood asthma: a meta-analysis of its efficacy

Theophylline in acute childhood asthma: a meta-analysis of its efficacy Theophylline in acute childhood asthma: a meta-analysis of its efficacy Theophylline in acute childhood asthma: a meta-analysis of its efficacy Goodman D C, Littenberg B, O'Connor G T, Brooks J G Authors' objectives To determine the efficacy of theophylline in children hospitalised with acute asthma. Searching MEDLINE was searched from 1966 to May 1994; details of the search strategy were given. Study selection Study (...) designs of evaluations included in the review Randomised controlled trials (RCTs) with study durations ranging from 24 to 36 hours, and until discharge, were included. Specific interventions included in the review IV Aminophylline or IV theophylline in the context of standard therapy for asthma, i.e. the treatment groups also received other bronchodilators and steroids, while the comparison groups received the same standard therapy, with the omission of theophylline. Participants included

DARE.1996

1180. Economic analysis of two structured treatment and teaching programs on asthma

Economic analysis of two structured treatment and teaching programs on asthma Economic analysis of two structured treatment and teaching programs on asthma Economic analysis of two structured treatment and teaching programs on asthma Neri M, Migliori G B, Spanevello A, Berra D, Nicolin E, Landoni C V, Ballardini L, Sommaruga M, Zanon P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Using a complete (CP) versus reduced (RP) educational programme on asthma to reduce the asthma-induced incidents in asthma patients. The CP group received six lessons based on an educational booklet and educational videotapes, while the RP group had only a self-reading of the same educational booklet. The patients in both programmes received peak

NHS Economic Evaluation Database.1996